Two models for radiological reviewing of interval cancers

Journal of Medical Screening

Volumn 6, Issue 1, 1999, Pages 35-39

  Moberg, Kerstin ^a   Grundström, Helene ^b   Törnberg, Sven ^c   Lundquist, Hans ^d   Svane, Gunilla ^c   Havervall, Lech ^e   Muren, Catharina ^a  

^a STOCKHOLM SÖDER HOSPITAL   (Sweden)

^b DANDERYD HOSPITAL   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d ST GÖRAN S HOSPITAL   (Sweden)

^e Department of Radiology ^*  (Sweden)

Author keywords

Breast neoplasm; Interval cancers; Mammography

Indexed keywords

ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER SCREENING; MAMMOGRAPHY; MASS SCREENING; POPULATION RESEARCH; QUALITY CONTROL; RADIOLOGY;

EID: 0032940712     PISSN: 09691413     EISSN: None     Source Type: Journal    
DOI: 10.1136/jms.6.1.35     Document Type: Article

References (23)

1. Tabar L, Fagerberg G, Duffy S, et al. Update of Swedish two-county program of mammographic screening for breast cancer. Radiol Clin North Am 1992;30:187-210.
2. Nyström L, Rutqvist LE, Wall S, et al. Breast cancer screening with mammography: overview of Swedish randomised trials. Lancet 1993;341:973-8.
3. Holland R, Mravunac M, Hendriks J, et al. So-called interval cancers of the breast. Cancer 1982;49:2527-33.
4. Martin J. Breast cancer missed by mammography. AJR 1979;132:737-9.
5. Buchanan J, Spratt J, Heuser L. Tumour growth, doubling times, and the inability of the radiologist to diagnose certain cancers. Radiol Clin North Am 1983;21:115-26.
6. Holmberg L, Tabar L, Adami H, et al. Survival in breast cancer diagnosed between mammographic screening examinations. Lancet 1986;ii:27-30.
7. Peeters P, Verbeek A, Hendriks J, et al. The occurrence of interval cancers in the Nijmegen screening program. Br J Cancer 1989;59:929-32.
8. Frisell J, von Rosen A, Wiege M, et al. Interval cancers and survival in a randomized breast cancer screening trial in Stockholm. Breast Cancer Res Treat 1992;24:11-16.
9. Ikeda D, Andersson I, Wattsgård G, et al. Interval carcinomas in the Malmö mammographic screening trial. AJR 1992;159:287-94.
10. Burhenne H, Burhenne L, Goldberg F, et al. Interval breast cancers in the screening mammography program of British Columbia. AJR 1994;162:1067-71.
11. Burell H, Sibbering B, Wilson A, et al. Screening interval breast cancers. Mammographic features and prognostic factors. Radiology 1996;199:811-17.
12. Brekelmans CT, van Gorps JM, Peeters PH, et al. Histopathology and growth rate of inteval breast carcinoma: characterisation of different subgroups. Cancer 1996;78: 1220-8.
13. Vitak B, Stål O, Månsson BA, et al. Interval cancers and cancers in non-attenders in the Östergötland mammographic screening programme. Duration between screening and diagnosis, S-face fraction and distant recurrence. Eur J Cancer 1997;33:1453-60.
14. Day N, McCann J, Camilleri-Ferrante C, et al. Monitoring interval cancers in breast screening programmes: the East Anglian experience. Quality Assurance Management Group of the East Anglian Breast Screening Programme. J Med Screen 1995;2:180-5.
15. Sylvester P A, Kutt E, Baird A, et al. Rate and classification of interval cancers in the breast screening programme. Ann R Coll Surg Engl 1997;79:276-7.
16. Quality assurance in epidemiology of breast cancer screening. Follow-up and ascertainment of interval cancers. European guidelines for quality assurance in mammography screening. 2nd ed. European Commission Public Health, 1996:IIA-37-39.
17. Simpson W, Neilson F, Young J R. The identification of false negatives in a population of interval cancers: a method for audit of screening mammography. The Breast 1995;4:183-8.
18. Duncan A, Wallis M. Classifying interval cancers. Clin Radiol 1995;50:774-7.
19. Lidbrink E, Törnberg S, Azavedo E, et al. The general mammography screening programme in Stockholm. Acta Oncol 1994;33:353-8.
20. Frisell J, Eklund G, Hellström L, et al. Randomized study of mammography screening - preliminary report on mortality in the Stockholm trial. Breast Cancer Res Treat 1991;18:49-56.
21. Frisell J, Lidbrink E, Hellström L, et al. Follow up after 11 years - update of mortality results in the Stockholm mammographic screening trial. Breast Cancer Res Treat 1997;45: 263-70.
22. Thurfjell E, Lernevall K, Taube A. Benefit of independent double reading in a population-based mammography screening program. Radiology 1994;191:241-4.
23. Thurfjell E. Mammography screening One versus two views and independent double reading. Acta Radiol 1994;35: 345-350.